Intellectual property law
fromIPWatchdog.com | Patents & Intellectual Property Law
2 days agoTo Beat China at Drug Innovation, Big Pharma and Generics Need the Supreme Court to End This Patent Absurdity
The Federal Circuit's panel-dependent jurisprudence and the "after-arising technology" exception enable patent evergreening, undermining U.S. biopharma competitiveness versus China.